[1] DE H M,DETRAUX J,VANCAMPFORT D.The intriguing relationship between coronary heart disease and mental disorders[J].Dialogues Clin Neurosci,2018,20(1):31-40. [2] RICHARDS S H,ANDERSON L,JENKINSON C E,et al. Psychological interventions for coronary heart disease: Cochrane systematic review and meta-analysis[J].Eur J Prev Cardiol,2018,25(3):247-259. [3] 亓国锋,李刚刚,李予春. 枣仁安神胶囊对冠心病伴焦虑抑郁患者疗效及血清5-HT、MPO水平的影响[J].中华中医药学刊,2018,36(3):681-684. [4] 张晓蕾,任岩春,赵永峰,等. 神经内分泌变化与冠心病合并焦虑症的关系[J].实用预防医学,2018,25(6):720-722. [5] KASPER S,HJ M,VOLZ H P,et al. Silexan in generalized anxiety disorder: investigation of the therapeutic dosage range in a pooled data set[J].Int Clin Psychopharmacol,2017,32(4):195-204. [6] 颜红兵. 临床冠心病诊断与治疗指南[M].北京:人民卫生出版社,2010:5-26. [7] BLUMENTHAL J A,SMITH P J,JIANG W,et al. Effect of exercise,escitalopram,or placebo on anxiety in patients with coronary heart disease: the understanding the benefits of exercise and escitalopram in anxious patients with coronary heart disease (UNWIND) randomized clinical trial[J].JAMA Psychiatry,2021,78(11):1270-1278. [8] 陈晨,李华,童全秀,等. 2型糖尿病合并冠心病患者心率变异性变化及其与心功能的相关性分析[J].实用临床医药杂志,2021,25(19):43-48. [9] 魏勇,梁琪,左浩源,等. 右美托咪定预处理对冠心病非心脏手术患者心肌的保护作用[J].陕西医学杂志,2019,48(12):1706-1709. [10] 刘雯晶,李珂,胡健才. 巴戟天寡糖胶囊对冠心病抑郁患者神经递质及抑郁程度的影响[J].心脑血管病防治,2018,18(3):243-244. [11] 熊庭旺,吴芹,刘杰,等. 基于神经递质途径抗焦虑中药及其复方研究进展[J].中国中药杂志,2020,45(1):14-19. [12] SCHIWECK C,PIETTE D,BERCKMANS D,et al. Heart rate and high frequency heart rate variability during stress as biomarker for clinical depression. A systematic review[J].Psychol Med,2019,49(2):200-211. [13] KIRCANSKI K,WILLIAMS L M,GOTLIB I H. Heart rate variability as a biomarker of anxious depression response to antidepressant medication[J].Depress Anxiety,2019,36(1):63-71.
2023, Vol. 40 
